Share

Tradeoffs
Tradeoffs Presents: The Fifth Branch
EMS, Fire, Police and the 911 Call Center make up the existing four branches of the public safety system. A special series from Tradeoffs and The Marshall Project explores how a city radically changes its response to people in crisis, by creating a fifth branch.
Nearly half of the country’s 50 largest cities - including San Francisco, New York, Houston, Chicago - have launched programs to send unarmed responders to 911 calls historically handled by cops. In the process creating a new generation of first responders made up of clinicians, EMTs and unarmed mental health workers all responding to people who struggle with addiction, homelessness and mental illness.
To understand this work we head to Durham, North Carolina, which has - in the face of skepticism and downright opposition - built one of the most comprehensive programs in the country.
How did Durham pull off what so many cities have struggled to do? Join Tradeoffs and The Marshall Project for our new series The Fifth Branch as we examine this groundbreaking work and the challenges it’s facing, both in Durham and around the country. Episodes drop July 18, July 25 and August 1.
Learn more on our website.
Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.
Support this type of journalism today, with a gift.
More episodes
View all episodes

366. Immigration Enforcement’s Twin Threats to Health Care
26:15||Season 1, Ep. 366Patients are afraid to show up to medical appointments, while workers are being detained, deported or losing their visa statuses.Guests:Sahida Martinez, promotora, EnlaceJadhira Sanchez, director of community health, EnlaceSteph Willding, CEO, CommunityHealthJordan Herring, Postdoctoral scholar, Emergency medicine, StanfordHannah Janeway, Emergency medicine physician, Los AngelesLaura Messineo, CNO, WorldWide HealthStaff Solutions Learn more and read a full transcript on our website.Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.Support this type of journalism today, with a gift.
365. As States and CDC Split on Vaccines, What's Next?
19:58||Season 1, Ep. 365Half of states have rejected federal vaccine guidance on childhood vaccines after controversial changes by the CDC. Public health experts say the split is sowing confusion and increasing the risk of outbreaks. Guests:Michelle Fiscus, physician, chief medical officer, Association of Immunization ManagersJen Kates, senior vice president; director, global and public health policy, KFF Tao Sheng Kwan-Gett, physician, health officer, Washington Department of HealthPhilip Landrigan, physician and director, program for global public health and the common good, Boston College Dorit Reiss, law professor, University of California, San FranciscoLearn more and read a full transcript on our website.Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.Support this type of journalism today, with a gift.
364. A Better Way to Care for Older Adults with Opioid Addiction
24:59||Season 1, Ep. 364How one addiction clinic in Baltimore has found success combining addiction care with support for the many other health problems older Americans often face.Guests:Malik Burnett, Medical Director, REACH Health ServicesLisa Clemans-Cope, Senior Research Fellow, Urban InstituteRenee Gray, Patient, REACH Health ServicesPhyllis Lindsay, Peer Recovery Specialist, REACH Health ServicesMaggie Lowenstein, Assistant Professor, Medicine, University of Pennsylvania Perelman School of MedicineVickie Walters, Executive Director, REACH Health ServicesLearn more and read a full transcript on our website.Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.Support this type of journalism today, with a gift.
363. Mental Illness Left Their Loved Ones on the Streets. California’s Big Fix Hasn’t Helped
24:10||Season 1, Ep. 363How Gov. Gavin Newsom’s ambitious plan to force more people into treatment left many families still searching for help.Guest(s):June DudasMarisa Kendall, homelessness reporter, CalMattersRead CalMatters full “Courting Disappointment” series here. Learn more and read a full transcript on our website.Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.Support this type of journalism today, with a gift.
362. One State's Sprint for its Share of $50 Billion for Rural Health: Part 2
24:27||Season 1, Ep. 362Maryland finds out how much the state will get from a nationwide competition for federal rural health investment.Guest(s):Christina Koontz, paramedic Elizabeth Kromm, assistant secretary for population health and strategic initiatives, Maryland Department of HealthMike Salvadge, chief of emergency medical services, Allegany County, Md. Meena Seshamani, Maryland secretary of healthHemi Tewarson, executive director, National Academy for State Health PolicyLearn more and read a full transcript on our website.Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.Support this type of journalism today, with a gift.
361. One State's Sprint for its Share of $50 Billion for Rural Health: Part 1
27:35||Season 1, Ep. 361We follow Maryland's 52-day rush to convince the Trump administration to give the state new funding to transform rural health care.Guests:Bonita Baer, Maryland residentMark Boucot, president and CEO of Garrett Regional Medical Center and Potomac Valley Hospital Elizabeth Kromm, assistant secretary for population health and strategic initiatives, Maryland Department of HealthLevi Lantz, ALL Produce & GreenhouseKen Ulman, former executive, Howard County, Maryland; president of Margrave StrategiesLearn more and read a full transcript on our website.Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.Support this type of journalism today, with a gift.
360. Race to the Bottom: Where's the Cavalry?
29:11||Season 1, Ep. 360Many potent new medicines pose a host of challenges for drug companies trying to copy and sell similar versions on the cheap. Can those companies find a sustainable path forward, or will patients get left stuck paying exorbitant prices?Guests:Christine Baeder, MBA, President, Apotex USAAlfred Engelberg, JD, retired attorney and former counsel to the Generic Pharmaceutical Industry AssociationJeremy Greene, MD, PhD, Professor of Medicine and the History of Medicine, Johns Hopkins UniversityCandy Meyer, PatientBhaven Sampat, PhD, Professor, Arizona State University School for the Future of Innovation in SocietyMarta Wosińska, PhD, Senior Fellow, Brookings InstitutionLeslie Walker, Senior Reporter/Producer, TradeoffsLearn more and read a full transcript on our website.Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.Support this type of journalism today, with a gift.
359. Breaking Down Trump’s $50 Billion Rural Health Fund
01:01:11||Season 1, Ep. 359Rural health experts dig into the Trump administration’s effort to transform rural health care.Guests:Kevin Bennett, Director Center for Rural & Primary Healthcare; Professor, Family and Preventative Medicine, School of Medicine Columbia, University of South CarolinaPaula Chatterjee, Director of Health Equity Research, Penn LDI; Assistant Professor, Medicine, Perelman School of MedicineSarah Jane Tribble, Chief Rural Correspondent, KFF Health NewsRachel Werner, Executive Director, Leonard Davis Institute of Health Economics; Professor of Medicine, Perelman School of Medicine, University of PennsylvaniaLearn more and read a full transcript on our website.Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.Support this type of journalism today, with a gift.
358. Race to the Bottom: Hard Bargain
29:44||Season 1, Ep. 358America pays less, on average, than any other major country for our generic drugs. But selling essential drugs at such low prices comes with hidden costs — from quality problems to frequent shortages.This is the second episode of Race to the Bottom, a three-part series by Tradeoffs on the problems plaguing the generic drugs we all rely on — and how we could fix them.Guests:Christine Baeder, MBA, President, Apotex USALaura Bray, MBA, Founder, Angels for ChangeCraig Burton, Senior Vice President of Policy and Strategic Alliances, Association for Accessible MedicinesIilun Murphy, MD, Director of the Office of Generic Drugs, FDALeslie Walker, Senior Reporter/Producer, TradeoffsMarta Wosińska, PhD, Senior Fellow, Brookings InstitutionLearn more and read a full transcript on our website.Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.Support this type of journalism today, with a gift.